Showing results (241-250 of 316) with videos related to
Sort By:
Pageof 32
Nature Communications|June 17, 2017
Corrigendum: Hepatic p63 regulates steatosis via IKKβ/ER stressBegoña Porteiro, Marcos F Fondevila, Teresa C Delgado, et al.Hepatology (Baltimore, Md.)|July 28, 2023
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.Alimentary Pharmacology & Therapeutics|October 25, 2018
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesityJavier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.JHEP Reports : Innovation in Hepatology|October 16, 2024
Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseasesEnrique García-Nieto, Juan Carlos Rodriguez-Duque, Coral Rivas-Rivas, et al.Nature Communications|May 9, 2017
Hepatic p63 regulates steatosis via IKKβ/ER stressBegoña Porteiro, Marcos F Fondevila, Teresa C Delgado, et al.Journal of Viral Hepatitis|March 3, 2026
Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence SynthesisChristos Thomadakis, Ilias Gountas, Konstantinos Gountas, et al.Plos One|March 21, 2017
A morphological method for ammonia detection in liverVirginia Gutiérrez-de-Juan, Sergio López de Davalillo, David Fernández-Ramos, et al.Hepatology (Baltimore, Md.)|December 31, 2016
Deregulated neddylation in liver fibrosisImanol Zubiete-Franco, Pablo Fernández-Tussy, Lucía Barbier-Torres, et al.Medicina Clinica|March 11, 2017
Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centersCarlos Rodríguez de Lope, María Reig, Ana Matilla, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 6, 2022
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk FactorsJuan Carlos Rodriguez-Duque, José Luis Calleja, Paula Iruzubieta, et al.Pageof 32